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Abstract 
Background: Recent advances in genome sequencing, combined with bioinformatic analysis, has led to the iden‑
tification of numerous novel natural product gene clusters, particularly in actinomycetes of terrestrial and marine 
origin. Many of these gene clusters encode uncharacterised Type III polyketide synthases. To facilitate the study of 
these genes and their potentially novel products, we set out to construct an actinomycete expression host specifically 
designed for the heterologous expression of Type III PKS genes and their gene clusters.
Results: A derivative of Streptomyces coelicolor A3(2) designed for the expression of Type III polyketide synthase (PKS) 
genes was constructed from the previously engineered expression strain S. coelicolor M1152 [Δact Δred Δcpk Δcda 
rpoB(C1298T)] by removal of all three of the endogenous Type III PKS genes (gcs, srsA, rppA) by PCR targeting. The 
resulting septuple deletion mutant, M1317, proved to be an effective surrogate host for the expression of actinobac‑
terial Type III PKS genes: expression of the reintroduced gcs gene from S. coelicolor and of the heterologous rppA gene 
from Streptomyces venezuelae under the control of the constitutive ermE* promoter resulted in copious production of 
germicidin and flaviolin, respectively.
Conclusions: The newly constructed expression host S. coelicolor M1317 should be particularly useful for the discov‑
ery and analysis of new Type III polyketide metabolites.
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Background
Type III polyketides are generally small molecules gen-
erated by Type III polyketide synthases (PKSs). These 
multifunctional ketosynthases typically utilise free CoA 
thioesters as substrates without the involvement of an 
acyl carrier protein (ACP), and frequently catalyse specific 
cyclization reactions found in aromatic and pyrone pol-
yketides [1, 2]. The recent explosion in genome sequenc-
ing, combined with bioinformatic analysis, has led to the 
identification of numerous uncharacterized Type III PKS 
genes in plants, fungi and bacteria, including actinomy-
cetes [1, 3–6]. Bacterial Type III PKSs are attractive to 
study for a number of reasons: they are widely distrib-
uted, make a variety of structurally different products and, 
compared to Type I and Type II PKSs, relatively simple to 
manipulate genetically [7]. Some Type III PKSs are solely 
responsible for product formation. For example, germi-
cidin synthase (Gcs) and the 1,3,6,8-tetrahydroxynaph-
thalene (THN) (RppA) synthases, commonly found in 
Streptomyces spp., are the only enzymes required to pro-
duce germicidin and THN, respectively [5, 8, 9]. THN can 
oxidise spontaneously to yield the red-brown pigment 
flaviolin, which is involved in bacterial melanin produc-
tion, although a cytochrome P450 monooxygenase was 
reported to be involved in the conversion of THN to flavi-
olin in Streptomyces antibioticus [6, 10, 11]. Some Type III 
PKS genes are organized in small operons, such as srsABC 
of Streptomyces griseus that produces alkylresorcinols 
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[12]. Such operons may also reside in complex gene clus-
ters where they provide a specific precursor for the bio-
synthesis of more elaborate specialized metabolites; for 
example, the dpgABCD operon that synthesizes dihy-
droxyphenylacetic acid which is used as a precursor for 
vancomycin, balhimycin, teicoplanin and kendomycin 
biosynthesis in Amycolatopsis orientalis [13], A. balhimy-
cina [14], Actinoplanes teichomyceticus [15] and Strepto-
myces violaceoruber [16], respectively.
Within the actinomycetes, Streptomyces species such 
as Streptomyces lividans TK24, Streptomyces coelicolor, 
Streptomyces avermitilis and Streptomyces albus J1074 
[17, 18] have been used as surrogate hosts for the het-
erologous expression of gene clusters encoding special-
ized metabolites. S. avermitilis, the industrial producer of 
avermectin [19, 20], and S. coelicolor, for many years the 
model species for the study of the genetics and biology of 
actinomycetes [21], have both been manipulated geneti-
cally to enhance the level of expression of heterologous 
gene clusters [22–25], and derivatives of each have been 
used to produce a range of different heterologous special-
ized metabolites [23, 24, 26–32]. In this work, we have 
further engineered S. coelicolor M1152 [24], a derivative 
of strain M145 from which four of the known antibiotic 
biosynthetic gene clusters had been deleted and which 
contains a mutation (C1298T) in rpoB that increases the 
level of secondary metabolite production, by removing all 
of its native Type III PKS genes. Deletion of the resident 
Type III PKS genes could potentially increase precursor 
pool levels and prevent undesirable interference with bio-
synthesis encoded by heterologous Type III PKS genes.
Results and discussion
Type III PKS genes in S. coelicolor
Analysis of the genome sequence of S. coelicolor M145 
revealed three endogenous Type III PKS genes: sco1206, 
sco7221 and sco7671 [33]. sco1206 encodes RppA which 
synthesizes 1,3,6,8-tetrahydroxynaphthalene (THN), the 
intermediate involved in bacterial melanin biosynthesis, 
by the condensation of five malonyl CoA molecules [8]. 
sco1206 lies upstream of sco1207 and sco1208 (Fig.  1), 
which are homologues of the characterized cytochrome 
P450 genes mel [6] and momA [10] in S. griseus and S. 
antibioticus, respectively; in each of these species, the 
single P450 gene lies adjacent to a rppA homologue. 
S. coelicolor thus differs in possessing two tandemly 
arranged P450 genes 3′ of the Type III PKS gene, with all 
three genes apparently translationally coupled. MomA 
was predicted to play a role in the oxidation of THN to 
form flaviolin [10], while Mel was thought to couple mol-
ecules of THN to generate hexahydroxyperylenequinone 
melanin [6]. Since S. coelicolor is not known to produce 
any of these three molecules, this gene cluster may not be 
expressed under commonly used laboratory growth con-
ditions. sco7221 was shown to play a role in germicidin 
biosynthesis [5, 34] and its product thus designated as 
germicidin synthase (Gcs). Analysis of Sco7671 revealed 
closest homology to a family of mycobacterial Type III 
PKSs [34]. sco7671, sco7669 and sco7670 are likely to 
form an operon (Fig. 1) organized in a similar fashion to 
srsABC of S. griseus (known to produce phenolic lipids, 
the alkylresorcinols) [12]. Although the function, sub-
strate specificity and the product profile of sco7671 have 
been investigated in  vitro [34], the final product of the 
gene cluster has not been identified. To generate a clean 
host for the heterologous expression of Type III PKS gene 
clusters, we set out to delete sco7221 (gcs), sco7669-7670-
7671 (the srs operon) and sco1206-1207-1208 (the rppA 
operon) from S. coelicolor M1152 [24].
Deletion of the three native Type III PKS genes and operons 
of S. coelicolor M1152
All three Type III PKS genes and operons were deleted 
from S. coelicolor M1152 by PCR targeting [35, 36] 
(Fig.  2; see reference 35 for a detailed description of 
PCR targeting). For two of the mutations (Δsco7221 and 
Δsco7669-7670-7671), in-frame deletions were generated 
in a two-step process; in the first step, the entire gene or 
operon in the corresponding cosmid was replaced with 
an apramycin (Apr) resistance cassette in Escherichia 
coli and the mutant allele then introduced into S. coeli-
color M1152 to create an AprR-marked mutant; in the 
second step, the AprR cassette in the cosmid was elimi-
nated in E. coli using FLP-recombinase to leave an 81 bp 
scar sequence which was then introduced into the AprR-
marked mutant, replacing the AprR cassette and creating 
an in-frame deletion mutant. Deletion of gcs (sco7221; 
1122  bp) yielded M1314, which was then used for the 
in-frame deletion of the srs operon (sco7669-7670-
7671; 2786 bp) to yield the double Type III PKS deletion 
mutant, M1316. Finally, the rppA operon (sco1206-1207-
1208; 2859  bp) was removed from M1316 by replace-
ment with the AprR cassette to yield the triple mutant 
M1317 (Fig. 2). Confirmation of the mutations in M1314, 
M1316 and M1317 was achieved by PCR amplification 
using primers flanking the deleted regions of the chro-
mosome followed by DNA sequencing (data not shown). 
With the previous removal of four antibiotic biosynthetic 
gene clusters (to generate M1152), the resulting septuple 
mutant M1317 has lost approximately 178 kb of chromo-
somal DNA compared to the parental strain M145.
All three deletion mutants grew and sporulated in a 
manner that was indistinguishable from M1152 when 
cultures were grown on SFM agar (data not shown).
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Validation of S. coelicolor M1317 as a host for the 
expression of Type III PKS genes
The well-characterized germicidin synthase gene of 
S. coelicolor was chosen initially to validate the utility 
of M1317 as a host for the expression of Type III PKS 
genes. gcs (sco7221), which is capable of producing five 
congeners [5], was inserted downstream of the consti-
tutive ermE* promoter in two bifunctional multi-copy 
vectors, pIJ86 and pIJ12477 (a derivative of pIJ86 confer-
ring kanamycin resistance), to give pIJ86 + sco7221 and 
pIJ12477  +  sco7221, respectively. pIJ86  +  sco7221 and 
pIJ86 were then transferred by conjugation into M1152 
to yield M1152/pIJ86  +  sco7221 and M1152/pIJ86, 
respectively, while pIJ12477  +  sco7221 and pIJ12477 
were transferred similarly to M1317 to obtain M1317/
pIJ12477  +  sco7221 and M1317/pIJ12477, respectively. 
Germicidin production was assessed by HPLC analysis 
of 5 days culture supernatants of all four strains (Fig. 3a), 
and the masses of the peaks corresponding to each ger-
micidin congener [5] confirmed by mass spectrom-
etry. While no production was observed, as expected, 
in M1317/pIJ12477, peaks corresponding to most of 
the germicidin congeners were detected in culture 
supernatants from the other three strains, with total pro-
duction levels in M1317/pIJ12477 + sco7221 and M1152/
pIJ86 + sco7221 10.7- and 7.8-fold higher than in M1152/
pIJ86, presumably at least partly attributable to the 
multi-copy nature of the vectors; production in M1317/
pIJ12477 + sco7221 was 1.4-fold higher than in M1152/
pIJ86 + sco7221, potentially reflecting increased precur-
sor supply in the septuple deletion mutant. In each case, 
germicidin A and germicidin B7 were the major products 
(Fig. 3; Table 1).
To evaluate the use of M1317 as a host for the het-
erologous expression of Type III PKS genes, the rppA 
homologue of S. venezuelae (sven5367) was cloned in 
pIJ12477 to yield pIJ12477 +  sven5367 which was intro-
duced into M1152 and M1317 to produce M1152/
pIJ12477  +  sven5367 and M1317/pIJ12477  +  sven5367, 
respectively. Both strains produced a red-brownish pig-
ment on IPM agar and in GYM liquid medium that 
was not observed in strains carrying the vectors alone 
(M1152/pIJ86 and M1317/pIJ12477) (Fig.  4). RppA ini-
tially generates 1,3,6,8-tetrahydroxynapthalene (THN) 
which is rapidly converted to flaviolin [6, 8]. Since we 
were unable to detect THN by chromatography, we 
Fig. 1 Genetic organisation of the three Type III PKS loci in S. coelicolor. sco7221 (gcs), sco1206‑1207‑1208 (rppA operon) and sco7669‑7670‑7671 (srs 
operon) targeted for deletion are shown as black arrows. Flanking genes are shown in grey together with their putative functions
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instead quantified flaviolin production. The mass of the 
HPLC peak corresponding to flaviolin was confirmed by 
mass spectrometry [37] (Fig. 5a). Flaviolin production was 
readily detected in both M1152/pIJ12477 + sven5367 and 
M1317/pIJ12477 + sven5367, while none was detected in 
M1152/pIJ86 and M1317/pIJ12477 (Fig. 5b; Table 1), thus 
establishing the utility of M1317 as a host for the heter-
ologous expression of Type III PKS genes. Production in 
M1317/pIJ12477 + sven5367 was 1.3-fold higher than in 
M1152/pIJ12477  +  sven5367, again potentially reflect-
ing increased precursor supply in the septuple deletion 
mutant. While some bacterial Type III PKSs, like plant 
chalcone and stilbene synthases [7], are sufficient alone 
for final product formation (e.g. the germicidin synthase 
of S. coelicolor [5] and the THN synthases of several Strep-
tomyces species [8, 38, 39]), some require a cytochrome 
P450 encoded by a neighbouring gene to convert the 
intermediate they produce into the final product, e.g. the 
THN synthase of S. antibioticus [10]. Interestingly, while 
rppA of S. venezuelae lies adjacent to a gene encoding a 
cytochrome P450 that may be required for flaviolin bio-
synthesis in that strain, expression of rppA alone was all 
that was required for heterologous production of flavio-
lin in S. coelicolor. It is possible that in this strain THN is 
either oxidized spontaneously to flaviolin or oxidized by 
one of the remaining 18 P450 monooxygenases encoded 
by the S. coelicolor genome [40]. 
Our inability to detect flaviolin production in M1152/
pIJ86 is consistent with previous work that also suggested 
that sco1206 is not expressed in S. coelicolor under stand-
ard laboratory conditions [8]. However, when the rppA 
operon of S. coelicolor (sco1206-1207-1208) expressed 
from the ermE* promoter was introduced into M1317 
to yield M1317/pIJ12477  +  sco1206-1207-1208, red-
brown pigment production occurred in both liquid- and 
agar-grown cultures. Flaviolin production in M1317/
pIJ12477 + sco1206-1207-1208 was confirmed by HPLC 
analysis and mass spectrometry (data not shown).
Fig. 2 Construction of Type III PKS deletion mutants of S. coelicolor M1152. Mutagenized cosmids introduced into each strain are indicated by their 
pIJ numbers
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Conclusions
We have successfully engineered the expression host S. 
coelicolor M1152 by removing all three of the endogenous 
Type III PKS gene and operons, and validated the result-
ing septuple deletion M1317 as a host for the ectopic 
and heterologous expression of Type III PKS genes. We 
believe that S. coelicolor M1317 will prove to be a useful 
strain for the future analysis of Type III PKS genes and 
their products from a wide range of actinomycetes.
Fig. 3 Germicidin production in derivatives of S. coelicolor M1152. a HPLC chromatogram and chemical structures of germicidin derivatives 
[5]. Mass spectroscopy confirmed the production of the following five germicidin congeners: 1, [M + H]+ = 197 m/z; 2, [M + H]+ = 197 m/z; 3, 
[M + H]+ = 183 m/z; 4 [M + H]+ = 183 m/z and 5, [M + H]+ = 183 m/z. The HPLC profiles for M1152 and M1317 were indistinguishable from those 
for M1152/pIJ86 and M1317/pIJ12477, respectively (data not shown). b Germicidin A, germicidin B7, and total germicidin production per mg dry 
weight of mycelium. The histograms show the average values obtained from duplicate cultures with the two individual measurements (Table 1) 
indicated by bars
Table 1 Relative levels of production of germicidins and flaviolin in engineered strains
ND not determined
Strain Relative production (mAU × 103)/mg dry weight
Germicidin A Germicidin B7 Total germicidins Flaviolin
M1152/pIJ86 0.44 ± 0.02 0.42 ± 0.08 0.86 ± 0.10 None
M1317/pIJ12477 None None None None
M1152/pIJ86 + sco7221 1.13 ± 0.14 5.58 ± 0.70 6.71 ± 0.84 ND
M1317/pIJ12477 + sco7221 1.88 ± 0.03 7.32 ± 0.27 9.19 ± 0.30 ND
M1152/pIJ12477 + sven5367 ND ND ND 1.72 ± 0.27
M1317/pIJ12477 + sven5367 ND ND ND 2.16 ± 0.05
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Methods
Bacterial strains, plasmids, cosmids and culture conditions
Bacterial strains, plasmids and cosmids used and 
generated in this study are listed in Table  2. Escheri-
chia coli strains were grown and manipulated following 
standard methods [35, 36, 41]. Media for the growth of 
Fig. 4 Red-brown pigment production after heterologous expression of the rppA homologue of S. venezuelae in S. coelicolor M1317/
pIJ12477 + sven5367 (a, c) compared to the same host containing the empty expression vector (M1317/pIJ12477) (b, d). a, b cultures grown in GYM 
liquid medium; c, d cultures grown on IPM agar
Fig. 5 Flaviolin production in derivatives of S. coelicolor M1152. a HPLC chromatogram of flaviolin (F) production in M1152/pIJ12477 + sven5367 
and M1317/pIJ12477 + sven5367; in each case, a mass of [M + H]− 205 m/z was confirmed by mass spectrometry (data for M1317/
pIJ12477 + sven5367 is shown in the inset). GA and GB7 indicate peaks of germicidin A and germicidin B7, respectively. The HPLC profiles for M1152 
and M1317 were indistinguishable from those for M1152/pIJ86 and M1317/pIJ12477, respectively (data not shown). b Flaviolin production per mg 
dry biomass weight. The histograms show the average values obtained from duplicate cultures with the two individual measurements (Table 1) 
indicated by the bars
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S. coelicolor strains were: instant potato mash (IPM) agar 
[42], SFM agar [43], tryptic soy broth (TSB) and glucose-
yeast extract-malt extract (GYM) medium [44]. Liquid 
cultures of Streptomyces strains were performed in 50 ml 
of medium in 250  ml flasks containing stainless steel 
springs at 30 °C with shaking at 250 rpm. The following 
antibiotics were used when required: 50 µg/ml apramycin 
(Apr), 50 µg/ml kanamycin (Kan), 50 µg/ml hygromycin 
(Hyg) and 25  µg/ml nalidixic acid (Nal). An overnight 
culture of each Streptomyces strain was used to inoculate 
50 ml of medium to give an initial OD600 nm = 0.1.
DNA manipulations for E. coli and Streptomyces
Extraction of DNA from E. coli was carried out using 
standard methods [36] or by using a QIAprep Spin 
Miniprep Kit (QIAGEN) and following the manufactur-
er’s instructions. Genomic DNA was isolated from Strep-
tomyces strains using the modified Kirby Mix procedure 
[43]. PCR amplifications for confirmation of engineered 
cosmids, mutant strains and expression constructs were 
performed using Taq DNA polymerase (QIAGEN). 
Expand High Fidelity PCR System (Roche) was used to 
amplify disruption cassettes [35] and Phusion® High-
Fidelity DNA Polymerase (NEB) was used to amplify 
PCR products for gene expression.
Deletion of the Type III PKS genes of S. coelicolor
The three native Type III PKS genes and operons of S. 
coelicolor (sco7221, sco7669-7670-7671 and sco1206-
1207-1208) were deleted from strain M1152 [24] by 
Table 2 Bacterial strains, plasmids and cosmids used and generated in this study
Strain/plasmid/cosmid Description Source of reference
Strain
 E. coli BT340 DH5α/pCP20 [45]
 E. coli BW25113 K‑12 derivative: ΔaraBAD, ΔrhaBAD [46]
 E. coli DH5α For cloning and propagation of host strain, deoR recA1 endA1 hsdR17(rk‑, mk+) phoA supE44 thi‑1 
gyrA96 relA1 λ−
Invitrogen, USA
 E. coli ET12567 dam‑13::Tn9 dcm‑6 hsdM hsdS [47]
 S. coelicolor M1152 Derivative of S. coelicolor M145, Δact Δred Δcpk Δcda rpoB(C1298T) [28]
 S. coelicolor M1314 S. coelicolor M1152 Δsco7221 This study
 S. coelicolor M1316 S. coelicolor M1152 Δsco7221 Δsco7669‑7670‑7671 This study
 S. coelicolor M1317 S. coelicolor M1152 Δsco7221 Δsco7669‑7670‑7671 Δsco1206‑1207‑1208::(oriT‑aac(3)IV) This study
Plasmid
 pGEM®‑T Easy E. coli vector for cloning PCR product, ampr Promega, USA
 pIJ86 ermEp*, aac(3)IV, oriT (RK2), ori (pIJ101), ori (pUC18) [48]
 pIJ773 pBluescript KS (+), aac(3)IV, oriT (RK2), FRT sites [35]
 pIJ790 λ‑RED (gam, bet, exo), cat, araC, rep101ts [35]
 pIJ10701 pBluescript KS (+), hyg, oriT (RK2), bla [35]
 pIJ12477 pIJ86, neo [49]
 pIJ13000 St2H12 Δsco7221::(oriT‑aac(3)IV) This study
 pIJ13001 St4C2 Δsco7669‑7670‑7671::(oriT‑aac(3)IV) This study
 pIJ13002 2StG58 Δsco1206‑1207‑1208::(oriT‑aac(3)IV) This study
 pIJ13003 St2H12 Δsco7221 This study
 pIJ13004 pIJ13003::(oriT‑hyg) This study
 pIJ13005 St4C2 Δsco7669‑7606‑7671 This study
 pIJ13006 pIJ13005::(oriT‑hyg) This study
 pIJ13007 2StG58 Δsco1206‑1207‑1208 This study
 pIJ13008 pIJ13007::(oriT‑hyg) This study
 pUZ8002 Kanr/tra, neo, RP4 [50]
Cosmid
 2StG58 SuperCos1 containing sco1206‑1207‑1208 John Innes Centre, UK
 St2H12 SuperCos1 containing sco7221 John Innes Centre, UK
 St4C2 SuperCos1 containing sco7669‑7670‑7671 John Innes Centre, UK
 Sv3G11 SuperCos1 containing sven5367 John Innes Centre, UK
 SuperCos1 neo, bla Agilent Technology, USA
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PCR targeting [35, 41]. Three pairs of flanking primers, 
SCO7221FSpe and SCO7221RNhe, SCO7671FSpe and 
SCO7669RNhe, and SCO1206FSpe and SCO1208RNhe 
(Table 3), were designed to amplify a 1458 bp fragment 
carrying an apramycin resistance (AprR) oriT cassette 
from pIJ773 [35]. Each of the AprR cassettes were flanked 
by 39 nt sequences matching the ends of the gene or 
operon to be deleted, and the targeted regions replaced 
with the AprR cassette by homologous recombination 
between these 39 nt sequences. Cosmids St2H12, St4C2 
and 2StG58, containing sco7221, sco7669-7670-7671 and 
sco1206-1207-1208, respectively, were transferred into E. 
coli BW25113 [47]/pIJ790 [35] and the resulting strains 
were then transformed with the corresponding replace-
ment cassette. The mutagenized cosmids pIJ13000, 
pIJ13001 and pIJ13002, respectively, were verified by 
restriction enzyme digestion and PCR amplification with 
primers SCO7221TF and SCO7221TR, SCO7671TF and 
SCO7669TR, and SCO1206TF and SCO1208TR, respec-
tively (Table  3). pIJ13000 (Δsco7221::(oriT-aac(3)IV)) 
was then introduced into S. coelicolor M1152 by conjuga-
tion with selection for apramycin resistance; subsequent 
screening for loss of kanamycin resistance (encoded by 
the SuperCos 1 vector) but retention of apramycin resist-
ance was used to isolate the required Δsco7221::(oriT-
aac(3)IV) replacement mutant. In the meantime, the 
AprR cassettes were removed from pIJ13000, pIJ13001 
and pIJ13002 in E. coli BT340 [46] using the FLP-recom-
binase, in each case leaving a 81  bp scar sequence in 
place of the cassette. The resulting non-transmissible 
cosmids, pIJ13003, pIJ13005 and pIJ13007, respectively, 
were confirmed by restriction enzyme digestion and PCR 
Table 3 Primers used in this study
Bolds indicate restriction sites
Primer Sequence 5′–3′ Description
pIJ86F1 ACGCCTGGTCGATGTCGGAC Sequencing primers for recombinant plasmids of pIJ86 and 
pIJ12477pIJ86R2 TGCGGTCAGTGCGTGTGTCG








Flanking primers for sco1206‑1207‑1208 disruption cassette
SCO1208RNhe GATCGCGCGGACGCTGGCCGGGATGCCGATCCGCTAAC‑
CGCTAGCTGTAGGCTGGAGCTGCTTC
SCO1206TF TCGAGCTGGCCAAGCTG Test primers for verification of AprR cassette replacements and 





SCO7221F1 AGTCGGTGCTCCGGCTGGAC Sequencing primer for internal sequence of sco7221









Flanking primers for sco7669‑7670‑7671 disruption cassette
SCO7669RNhe GTCCGCTACGCGCGCGCCGCGCGGGGCCGGAACG‑
GCTCAGCTAGCTGTAGGCTGGAGCTGCTTC
SVEN5367F1 GGCCCGACACCGAGGACTG Sequencing primer for internal sequence of sven5367
SVEN5367FBamHI AAAAAGGATCCCGGGTGAGTGTGGGCGGCAGTTC PCR of sven5367 for cloning into pIJ12477
SVEN5367RHindIII AAAAAAAGCTTTCAGGCGACGGACGTGCGGG
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amplification using the same primer sets that were used 
for verification of the AprR cassettes (Table 3). To allow 
transfer of these cosmids from E. coli to Streptomyces via 
conjugation, a bla-oriT-hyg-bla cassette was amplified 
from pIJ10701 [35] and used to target the bla gene in the 
SuperCos1 backbone of pIJ13003, pIJ3005 and pIJ13007, 
yielding pIJ13004, pIJ13006 and pIJ13008, respectively. 
Intergeneric conjugation between the S. coelicolor 
Δsco7221::(oriT-aac(3)IV) replacement mutant and E. 
coli ET12567/pUZ8002 [47, 50] containing pIJ13004 was 
performed as previously described [35, 41]. Exconju-
gants were selected based on hygromycin resistance and 
the desired Δsco7221 in-frame deletion mutant M1314 
obtained by screening for Apr, Kan and Hyg sensitive seg-
regants and confirmed by sequencing of the PCR product 
obtained from genomic DNA using primers SCO7221TF 
and SCO7221TR. Essentially the same procedure was 
used to generate the double in-frame deletion mutant 
M1316 (Δsco7221, Δsco7669-7671) from M1314 using 
pIJ13001 and pIJ13006 (and confirmed by sequencing the 
PCR amplicon obtained from genomic DNA using PCR 
primers SCO7671TF and SCO7669TR). Similarly the tri-
ple deletion mutant M1317 (Δsco7221, Δsco7669-7671, 
Δsco1206-1208::aac(3)IV) was derived from M1316 
using pIJ13002. Despite repeated attempts, it was not 
possible to remove the AprR cassette from M1317 using 
pIJ13008. Therefore, M1317 was confirmed by sequenc-
ing of the PCR product obtained from genomic DNA 
using PCR primers SCO1206TF and SCO1208TR. In 
each case the PCR fragment was cloned into pGEM®-T 
Easy and sequenced using M13 universal primers to ver-
ify that the expected deletions had been made.
The three mutants were grown on SFM agar until spor-
ulation. Spores were harvested and stored in 20 % glyc-
erol at −20 °C.
Construction of the type III PKS expression strains
sco7221 (gcs) and sco1206-sco1207-sco1208 (rppA 
operon) from S. coelicolor and sven5367 (rppA homo-
logue) from S. venezuelae were amplified from cosmids 
St2H12, 2StG58 and Sv3G11, respectively, using primers 
SCO7221FBamHI and SCO7221RHindIII, SCO1206FB-
glII and SCO1206RHindIII, and SVEN5367FBamHI and 
SVEN5367RHindIII, respectively (Table  3). The forward 
(F) primers were designed to include the ribosome bind-
ing sites of sco7221, sco1206 and sven5367, respectively. 
The PCR products were cloned into pGEM®-T Easy and 
confirmed by restriction enzyme digestion and DNA 
sequencing using M13 universal primers and the internal 
primers SCO7221F1 for pGEM-T/sco7221, SCO1206F1, 
SCO1206F2, SCO1206F3 and SCO1206F4 for pGEM-
T/sco1206-sco1207-sco1208, and SVEN5367F1 for 
pGEM-T/sven5367 (Table 3). Two multi-copy expression 
vectors, each containing the constitutive ermE* pro-
moter, were used; pIJ86 [48] was employed in M1152, 
while pIJ12477 [49] (a derivative of pIJ86 also conferring 
kanamycin resistance) was used in M1152 and in M1317. 
sco7221 was sub-cloned as a BamHI–HindIII fragment 
into both pIJ86 and pIJ12477, yielding pIJ86 +  sco7221 
and pIJ12477  +  sco7221, respectively. sco1206-sco1207-
sco1208 (rppA operon) were sub-cloned as a BglII–Hin-
dIII fragment into BamHI plus HindIII cleaved pIJ12477, 
yielding pIJ12477 +  sco1206-sco1207-sco1208. sven5367 
was sub-cloned as a BamHI–HindIII fragment into 
pIJ12477 to obtain pIJ12477 + sven5367. Primers pIJ86F1 
and pIJ86R2 (Table 3), which anneal 220 and 229 bp from 
the BamHI and HindIII cloning sites, respectively, were 
used to verify the recombinant plasmids by PCR amplifi-
cation and sequencing in addition to restriction enzyme 
digestion. For pIJ12477  +  sco1206-sco1207-sco1208, 
primers pIJ86F1 and the internal primers SCO1206F1, 
SCO1206F2, SCO1206F3 and SCO1206F4 were also used 
for sequencing. The plasmids were then introduced into 
E. coli ET12567/pUZ8002 by transformation and trans-
ferred to the appropriate Streptomyces host by conjuga-
tion as described previously [43]. Exconjugants were 
selected on SFM agar containing 50 µg/ml apramycin or 
50  µg/ml kanamycin as appropriate and 25  µg/ml nali-
dixic acid. Spore stocks were prepared on SFM agar con-
taining the appropriate antibiotic for plasmid selection 
and stored in 20 % glycerol at −20 °C.
Analysis of germicidin and flaviolin production
Cultures were grown for 5 days in 50 ml of GYM liquid 
medium, 5  ml of each culture supernatant lyophilized, 
the dried samples dissolved in 500 µl water and filtered 
through a VectaSpin Micro Polysulphone 0.2 µm column 
(Whatman). The samples were injected onto a Phenom-
enex Gemini-NX3u C18 110A, 150 × 4.6 mm column fit-
ted to an Agilent 1100 HPLC system and analyzed using 
a linear methanol:water gradient in 0.1  % (w/v) formic 
acid as follows: 0 min, 10 % methanol; 1 min, 25 % metha-
nol; 21 min, 100 % methanol; 25.50 min, 10 % methanol; 
33 min, 10 % methanol, at a flow rate of 0.8 ml/min with 
UV absorbance monitoring at 280 nm. Fractions of inter-
est were collected and analyzed by mass spectrometry 
(Thermo Scientific™). Germicidins were analyzed using 
positive ion mode mass spectrometry whereas flaviolin 
was analyzed using negative ion mode. Each experiment 
was carried out in duplicate. The mycelium from each 
50 ml culture was harvested by centrifugation, dried and 
the dry weight determined. Relative levels of germicidin 
and flaviolin production were calculated by multiply-
ing the average peak area (mAU) obtained from a 5  ml 
sample by ten and dividing by the average dry weight 
obtained from a 50 ml culture.
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